ClinicalTrials.Veeva

Menu

Acute Neurocardiogenic Injury After Subarachnoid Hemorrhage. (HSA-2)

D

Direction Centrale du Service de Santé des Armées

Status

Completed

Conditions

Subarachnoid Hemorrhage

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to describe acute neurocardiogenic injury after subarachnoid hemorrhage assessed with cardiac 123I-MIBG scintigraphy and 18F-FDG PET/CT during the first week and the first six months after SAH.

The study hypothesis is that the evolution of the cardiac disturbances follows the clinical evolution.

Full description

The cardiac metabolic disturbance are assessed by a 18F-FDG PET/CT in the first week after SAH and monthly until normal result.

The myocardial sympathetic innervation is assessed by a cardiac 123I-MIBG scintigraphy in the first week after SAH and six months later.

Clinical outcome is assessed by Glasgow Outcome Scale, modified Rankin Scale and MOS-SF36 at 1, 3 and 6 months after SAH.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age
  • SAH
  • Hospitalization in the Military Teaching Hospital Sainte Anne

Exclusion criteria

  • Refusal of consent

Trial design

30 participants in 1 patient group

Subarachnoid hemorrhage
Description:
Patients presenting a SAH

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems